Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HeartSciences (HSCS) Return on Capital Employed (2022 - 2025)

Historic Return on Capital Employed for HeartSciences (HSCS) over the last 4 years, with Q4 2025 value amounting to 1.77%.

  • HeartSciences' Return on Capital Employed fell 1800.0% to 1.77% in Q4 2025 from the same period last year, while for Oct 2025 it was 1.77%, marking a year-over-year decrease of 1800.0%. This contributed to the annual value of 2.64% for FY2025, which is 12900.0% down from last year.
  • According to the latest figures from Q4 2025, HeartSciences' Return on Capital Employed is 1.77%, which was down 1800.0% from 3.52% recorded in Q3 2025.
  • Over the past 5 years, HeartSciences' Return on Capital Employed peaked at 5.54% during Q4 2023, and registered a low of 6.63% during Q2 2025.
  • Moreover, its 4-year median value for Return on Capital Employed was 2.51% (2022), whereas its average is 2.27%.
  • As far as peak fluctuations go, HeartSciences' Return on Capital Employed skyrocketed by 86400bps in 2023, and later crashed by -71400bps in 2024.
  • Over the past 4 years, HeartSciences' Return on Capital Employed (Quarter) stood at 3.09% in 2022, then surged by 279bps to 5.54% in 2023, then crashed by -129bps to 1.59% in 2024, then dropped by -11bps to 1.77% in 2025.
  • Its Return on Capital Employed was 1.77% in Q4 2025, compared to 3.52% in Q3 2025 and 6.63% in Q2 2025.